Silence Therapeutics Plc (SLNCF)
4.00
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Silence Therapeutics Cash from Investing (Quarterly) : 64.78M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.78M |
| March 31, 2026 | 10.00M |
| December 31, 2025 | -53.92M |
| September 30, 2025 | 52.79M |
| June 30, 2025 | -2.919M |
| March 31, 2025 | -44.38M |
| September 30, 2024 | -38.09M |
| June 30, 2024 | -0.0845M |
| March 31, 2024 | -49.91M |
| Date | Value |
|---|---|
| December 31, 2023 | -0.0012M |
| September 30, 2023 | 25.41M |
| June 30, 2023 | -5.728M |
| March 31, 2023 | -0.0401M |
| December 31, 2022 | -19.27M |
| September 30, 2022 | -0.0553M |
| June 30, 2022 | -0.0464M |
| March 31, 2022 | -0.0711M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0453M |
| Mereo BioPharma Group Plc | -0.0004M |
| Compass Pathways Plc | 0.00 |
| HemoGenyx Pharmaceuticals Plc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.548M |
| Cash from Financing (Quarterly) | 0.002M |
| Free Cash Flow | -41.79M |
| Free Cash Flow Per Share (Quarterly) | 0.0109 |
| Free Cash Flow to Equity (Quarterly) | 1.572M |
| Free Cash Flow to Firm (Quarterly) | 1.548M |
| Free Cash Flow Yield | -7.37% |